Teva Turns the Corner

Teva Turns the Corner

After a tumultuous year of ups and downs, Teva Pharmaceuticals seems to be slowly turning the corner. The Israel based company saw a significant downturn in performance during 2017 attributed in part to shortsightedness of trends in the market, too rapid growth and leveraging, and most critically, failure to diversify its portfolio. Its focus on […]